Saturday, June 20, 2026
Home Authors Posts by Ogkologos

Ogkologos

4259 POSTS 0 COMMENTS

EMA Recommends Extension of Indications for Cabozantinib

Ogkologos -
0

Switching to Camizestrant While Continuing a CDK4/6 Inhibitor After ESR1 Mutation...

Ogkologos -
0

Measurable Residual Disease Adapted Consolidation Strategy After Quadruplet Induction Therapy for...

Ogkologos -
0

Adding Neoadjuvant and Adjuvant Pembrolizumab to Standard Care Significantly Improves EFS...

Ogkologos -
0

ESMO Call for Stronger Cancer Prevention and Care Mirrored in WHO...

Ogkologos -
0

ESMO Welcomes the European Commission’s Life Sciences Strategy: A Vital Step...

Ogkologos -
0

FDA Approves Taletrectinib for ROS1-positive Non-Small Cell Lung Cancer

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Nirogacestat

Ogkologos -
0

Trastuzumab Deruxtecan Prolongs OS in Second-Line Treatment for Patients with HER2-positive...

Ogkologos -
0

ESMO Calls for Oncology-Specific Safeguards in EU Joint Clinical Assessments of...

Ogkologos -
0
1...313233...426Page 32 of 426

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com